comparemela.com
Latest Breaking News On - Pfizer inc nurtec - Page 1 : comparemela.com
Eli Lilly's migraine drug fails to meet main goal in post-approval study
Eli Lilly said on Friday its drug Emgality did not meet the primary goal of superiority to Pfizer Inc s Nurtec ODT in prevention of episodic migraine in a post-approval study. This was. | June 16, 2023
Bengaluru
Karnataka
India
Lilly-emgality
Shinjini-ganguli
Eli-lilly
Leroy-leo
Reuters
Pfizer-inc-nurtec
Pfizer-inc
Eli-lilly-and-company-stock-exchange
News
vimarsana © 2020. All Rights Reserved.